This is the authors' abstract. We don't add key points for this paper.
The effects of cyclophosphamide given for 18 weeks in small daily doses on CFU-S, CFU-C, and CFU-E content in mice bone marrow and spleen were studied. In the bone marrow, after an initial drop, the stem cell content rises above the normal values and remains there throughout a long period. In the spleen the stem cell content shows an initial several fold increase followed by a steady decline. It seems possible that this behaviour reflects a compensative effect to the toxic action of the drug at more differentiated levels of the haemopoietic cells.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Pannacciulli et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: